{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:09:50Z","timestamp":1786118990743,"version":"build-2736575974"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:p>Carcinoma simultaneously involving the endometrium and ovary is encountered frequently enough in clinical practice that guidelines are needed for consistent surgical pathology reporting and patient management. This review will cover the history and terminology of this phenomenon, summarize current practices, and provide a practical reporting framework for daily use. By focusing on conventional surgical pathology parameters, including molecular subtype, while avoiding clonality considerations, it is possible to consistently provide the necessary information to guide treatment. There remain some outstanding issues that require further research, which will be identified and discussed.<\/jats:p>","DOI":"10.1097\/pgp.0000000000001177","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T10:00:16Z","timestamp":1776765616000},"page":"304-310","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Coexistent Endometrial and Ovarian Carcinoma: Terminology, Clinicopathological Features, and Clinical Significance"],"prefix":"10.1097","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2685-0877","authenticated-orcid":false,"given":"Jutta","family":"Huvila","sequence":"first","affiliation":[{"name":"Department of Pathology, University of Turku, Turku University Hospital, Turku, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Blake","family":"Gilks","sequence":"additional","affiliation":[{"name":"Department of Pathology, Vancouver General Hospital and the University of British Columbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica N.","family":"McAlpine","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of British Columbia, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Jamieson","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of British Columbia, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"key":"R1-20260615","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/ijc.32907","article-title":"Molecular profiling identifies synchronous endometrial and ovarian cancers as metastatic endometrial cancer with favorable clinical outcome","volume":"147","author":"Reijnen","year":"2020","journal-title":"Int J Cancer"},{"key":"R2-20260615","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ygyno.2004.05.006","article-title":"Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases","volume":"94","author":"Soliman","year":"2004","journal-title":"Gynecol Oncol"},{"key":"R3-20260615","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ygyno.2018.10.033","article-title":"Risk-based stratification of carcinomas concurrently involving the endometrium and ovary","volume":"152","author":"Turashvili","year":"2019","journal-title":"Gynecol Oncol"},{"key":"R4-20260615","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0046-8177(85)80210-0","article-title":"Metastatic and independent cancers of the endometrium and ovary: a clinicopathologic study of 34 cases","volume":"16","author":"Ulbright","year":"1985","journal-title":"Hum Pathol"},{"key":"R5-20260615","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.3802\/jgo.2019.30.e7","article-title":"Prognostic factors of synchronous endometrial and ovarian endometrioid carcinoma","volume":"30","author":"Yoneoka","year":"2019","journal-title":"J Gynecol Oncol"},{"key":"R6-20260615","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1006\/gyno.2001.6400","article-title":"Simultaneously detected endometrial and ovarian carcinomas\u2014a prospective clinicopathologic study of 74 cases: a gynecologic oncology group study","volume":"83","author":"Zaino","year":"2001","journal-title":"Gynecol Oncol"},{"key":"R7-20260615","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.32604\/or.2025.068432","article-title":"Molecular pathology of ovarian endometrioid carcinoma: a review","volume":"33","author":"Yoshida","year":"2025","journal-title":"Oncol Res"},{"key":"R8-20260615","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/01.AOG.0000172423.64995.6f","article-title":"Coexisting ovarian malignancy in young women with endometrial cancer","volume":"106","author":"Walsh","year":"2005","journal-title":"Obstet Gynecol"},{"key":"R9-20260615","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ygyno.2013.09.009","article-title":"Synchronous primary cancers of the endometrium and ovary in young women: a Korean Gynecologic Oncology Group Study","volume":"131","author":"Song","year":"2013","journal-title":"Gynecol Oncol"},{"key":"R10-20260615","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1136\/ijgc-2023-005194","article-title":"Molecular and pathologic data to guide selection of patients with endometrioid endometrial cancer for ovarian preservation","volume":"34","author":"Manning-Geist","year":"2024","journal-title":"Int J Gynecol Cancer"},{"key":"R11-20260615","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.gore.2018.12.009","article-title":"Synchronous carcinomas of endometrium and ovary: a pragmatic approach","volume":"27","author":"Gilks","year":"2019","journal-title":"Gynecol Oncol Rep"},{"key":"R13-20260615","doi-asserted-by":"crossref","first-page":"e420","DOI":"10.1016\/S1470-2045(24)00192-X","article-title":"Clinical research in endometrial cancer: consensus recommendations from the Gynecologic Cancer InterGroup","volume":"25","author":"Creutzberg","year":"2024","journal-title":"Lancet Oncol"},{"key":"R14-20260615","doi-asserted-by":"crossref","first-page":"101957","DOI":"10.1016\/j.ijgc.2025.101957","article-title":"Co-existent endometrial and ovarian carcinoma: molecular and pathological features define low risk entity","volume":"35","author":"Jamieson","year":"2025","journal-title":"Int J Gynecol Cancer"},{"key":"R15-20260615","doi-asserted-by":"crossref","first-page":"djv428","DOI":"10.1093\/jnci\/djv428","article-title":"Synchronous endometrial and ovarian carcinomas: evidence of clonality","volume":"108","author":"Anglesio","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"R16-20260615","doi-asserted-by":"crossref","first-page":"djv427","DOI":"10.1093\/jnci\/djv427","article-title":"Massively parallel sequencing-based clonality analysis of synchronous endometrioid endometrial and ovarian carcinomas","volume":"108","author":"Schultheis","year":"2016","journal-title":"J Natl Cancer Inst"},{"issue":"suppl 1","key":"R18-20260615","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1097\/PGP.0000000000000553","article-title":"Guidelines to aid in the distinction of endometrial and endocervical carcinomas, and the distinction of independent primary carcinomas of the endometrium and adnexa from metastatic spread between these and other sites","volume":"38","author":"Stewart","year":"2019","journal-title":"Int J Gynecol Pathol"},{"key":"R19-20260615","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/ijgo.14923","article-title":"FIGO staging of endometrial cancer: 2023","volume":"162","author":"Berek","year":"2023","journal-title":"Int J Gynaecol Obstet"},{"key":"R20-20260615","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ygyno.2024.04.016","article-title":"Prognostic performance of the 2023 FIGO staging schema for endometrial cancer","volume":"187","author":"Matsuo","year":"2024","journal-title":"Gynecol Oncol"},{"key":"R21-20260615","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/bjc.2015.190","article-title":"A clinically applicable molecular-based classification for endometrial cancers","volume":"113","author":"Talhouk","year":"2015","journal-title":"Br J Cancer"},{"key":"R22-20260615","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1158\/1078-0432.CCR-15-2878","article-title":"Improved risk assessment by integrating molecular and clinicopathological factors in early-stage endometrial cancer-combined analysis of the PORTEC cohorts","volume":"22","author":"Stelloo","year":"2016","journal-title":"Clin Cancer Res"},{"key":"R23-20260615","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/cncr.30496","article-title":"Confirmation of ProMisE: a simple, genomics-based clinical classifier for endometrial cancer","volume":"123","author":"Talhouk","year":"2017","journal-title":"Cancer"},{"key":"R24-20260615","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/annonc\/mdy058","article-title":"Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series","volume":"29","author":"Kommoss","year":"2018","journal-title":"Ann Oncol"},{"key":"R25-20260615","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1200\/JCO.20.00549","article-title":"Molecular classification of the PORTEC-3 trial for high-risk endometrial cancer: impact on prognosis and benefit from adjuvant therapy","volume":"38","author":"Le\u00f3n-Castillo","year":"2020","journal-title":"J Clin Oncol"},{"key":"R26-20260615","doi-asserted-by":"crossref","first-page":"210","DOI":"10.6004\/jnccn.2022.7096","article-title":"Molecular profiling of endometrial cancer from TCGA to clinical practice","volume":"21","author":"Jamieson","year":"2023","journal-title":"J Natl Compr Canc Netw"},{"key":"R27-20260615","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ygyno.2023.01.025","article-title":"Molecular subtype stratified outcomes according to adjuvant therapy in endometrial cancer","volume":"170","author":"Jamieson","year":"2023","journal-title":"Gynecol Oncol"},{"key":"R28-20260615","doi-asserted-by":"crossref","first-page":"4369","DOI":"10.1200\/JCO.23.00062","article-title":"Molecular classification predicts response to radiotherapy in the randomized PORTEC-1 and PORTEC-2 trials for early-stage endometrioid endometrial cancer","volume":"41","author":"Horeweg","year":"2023","journal-title":"J Clin Oncol"},{"key":"R29-20260615","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/S1470-2045(25)00379-1","article-title":"Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): 10-year clinical outcomes and post-hoc analysis by molecular classification from a randomised phase 3 trial","volume":"26","author":"Post","year":"2025","journal-title":"Lancet Oncol"},{"key":"R30-20260615","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1470-2045(25)00612-6","article-title":"Molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer (PORTEC-4a): results of a randomised, open-label, phase 3, multicentre, non-inferiority trial","volume":"27","author":"van den Heerik","year":"2026","journal-title":"Lancet Oncol"},{"key":"R31-20260615","doi-asserted-by":"crossref","first-page":"e423","DOI":"10.1016\/S1470-2045(25)00167-6","article-title":"ESGO-ESTRO-ESP guidelines for the management of patients with endometrial carcinoma: update 2025","volume":"26","author":"Concin","year":"2025","journal-title":"Lancet Oncol"},{"key":"R32-20260615","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1002\/cncr.33516","article-title":"Evaluation of treatment effects in patients with endometrial cancer and POLE mutations: an individual patient data meta-analysis","volume":"127","author":"McAlpine","year":"2021","journal-title":"Cancer"},{"key":"R33-20260615","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ygyno.2026.01.233","article-title":"Substratification of mismatch repair deficient endometrial cancers based on mechanism of MMR loss can provide prognostic and predictive refinement","volume":"205","author":"Jamieson","year":"2026","journal-title":"Gynecol Oncol"},{"key":"R34-20260615","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/ijgc-2023-005149","article-title":"Recurrence rates and patterns of recurrence in stage IA p53abn endometrial cancer with and without myometrial invasion","volume":"34","author":"Jamieson","year":"2024","journal-title":"Int J Gynecol Cancer"},{"key":"R35-20260615","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/PGP.0000000000001120","article-title":"Histotype and grade are of prognostic significance in the no specific molecular profile molecular subtype of endometrial carcinoma but not in POLE mut, MMRd, or p53abn endometrial carcinomas: results from a 2478 case series and a systematic review of the literature","volume":"44","author":"Huvila","year":"2025","journal-title":"Int J Gynecol Pathol"},{"key":"R36-20260615","doi-asserted-by":"crossref","first-page":"100085","DOI":"10.1016\/j.modpat.2022.100085","article-title":"Grade and estrogen receptor expression identify a subset of no specific molecular profile endometrial carcinomas at a very low risk of disease-specific death","volume":"36","author":"Jamieson","year":"2023","journal-title":"Mod Pathol"},{"key":"R37-20260615","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1038\/s41416-023-02141-0","article-title":"Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry","volume":"128","author":"Vermij","year":"2023","journal-title":"Br J Cancer"},{"key":"R38-20260615","doi-asserted-by":"crossref","first-page":"102832","DOI":"10.1016\/j.ijgc.2025.102832","article-title":"Role of adjuvant therapy de-escalation for low-grade endometrioid endometrial cancer with adnexal only metastasis: call for research","volume":"36","author":"Erfani","year":"2026","journal-title":"Int J Gynecol Cancer"},{"key":"R39-20260615","doi-asserted-by":"crossref","first-page":"4886","DOI":"10.1002\/cncr.33144","article-title":"Performance characteristics of screening strategies to identify Lynch syndrome in women with ovarian cancer","volume":"126","author":"Kim","year":"2020","journal-title":"Cancer"},{"key":"R40-20260615","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ygyno.2022.12.008","article-title":"Mismatch-repair deficiency, microsatellite instability, and lynch syndrome in ovarian cancer: a systematic review and meta-analysis","volume":"170","author":"Mitric","year":"2023","journal-title":"Gynecol Oncol"},{"key":"R41-20260615","doi-asserted-by":"crossref","first-page":"9344","DOI":"10.1200\/JCO.2005.03.5915","article-title":"Women with synchronous primary cancers of the endometrium and ovary: do they have Lynch syndrome?","volume":"23","author":"Soliman","year":"2005","journal-title":"J Clin Oncol"},{"key":"R42-20260615","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1097\/01.pas.0000209839.00467.05","article-title":"Endometrioid carcinoma simultaneously involving the uterus and the fallopian tube: a clinicopathologic study of 13 cases","volume":"30","author":"Culton","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R43-20260615","doi-asserted-by":"crossref","first-page":"103267","DOI":"10.1016\/j.labinv.2024.103267","article-title":"Abstract 1033 USCAP 2025. Endometrial carcinoma with isolated fallopian tube involvement, characterization of an uncommon finding","volume":"105","author":"Mathew","year":"2025","journal-title":"Laboratory Investigation"},{"key":"R44-20260615","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/his.15232","article-title":"Molecular classification of metastatic and recurrent endometrial endometrioid carcinoma: prognostic relevance among low- and high-stage tumours","volume":"85","author":"McHenry","year":"2024","journal-title":"Histopathology"}],"container-title":["International Journal of Gynecological Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/PGP.0000000000001177","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:08:08Z","timestamp":1786036088000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/PGP.0000000000001177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/pgp.0000000000001177","relation":{},"ISSN":["0277-1691","1538-7151"],"issn-type":[{"value":"0277-1691","type":"print"},{"value":"1538-7151","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]}}}